Oruka Therapeutics, Inc. (ORKA)
NASDAQ: ORKA · Real-Time Price · USD
104.04
+1.62 (1.58%)
Aug 25, 2026, 11:11 AM EDT - Market open
Oruka Therapeutics Market Cap
Oruka Therapeutics has a market cap or net worth of $6.89 billion as of August 25, 2026. Its market cap has increased by 1,091.67% in one year.
Market Cap
6.89B
Enterprise Value
5.77B
1-Year Change
1,091.67%
Ranking
Category
Stock Price
$104.04
ChartMarket Cap Chart
Since August 30, 2024, Oruka Therapeutics's market cap has increased from $849.32M to $6.89B, an increase of 711.05%. That is a compound annual growth rate of 186.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2026 | 6.89B | 369.47% |
| Dec 31, 2025 | 1.47B | 116.22% |
| Dec 31, 2024 | 678.62M | -20.10% |
| Aug 30, 2024 | 849.32M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmunityBio | 8.26B |
| TG Therapeutics | 7.70B |
| Rhythm Pharmaceuticals | 7.57B |
| Caris Life Sciences | 7.42B |
| CG Oncology | 7.07B |
| Scholar Rock Holding | 6.88B |
| Belite Bio | 6.49B |
| Cogent Biosciences | 6.38B |